Hepatocyte-targeted fluorescent nanoparticles based on a polyaspartamide for potential theranostic applications-Reference-Cited by-同舟云学术

Hepatocyte-targeted fluorescent nanoparticles based on a polyaspartamide for potential theranostic applications

Published:2015-07 Issue: Volume:70 Page:257-270
ISSN:0032-3861
Container-title:Polymer
language:en
Short-container-title:Polymer

Author:

Craparo Emanuela Fabiola,Licciardi Mariano,Conigliaro Alice,Palumbo Fabio Salvatore,Giammona Gaetano,Alessandro Riccardo,De Leo Giacomo,Cavallaro Gennara

Funder

Università degli Studi di Palermo

Ministero dell’Istruzione, dell’Università e della Ricerca

Publisher

Elsevier BV

Subject

Polymers and Plastics,Materials Chemistry,Organic Chemistry

Reference38 articles.

1. Fluorescence imaging of cancer tissue based on metal-free polymeric nanoparticles – a review

2. Multifunctional Micelles for Cancer Cell Targeting, Distribution Imaging, and Anticancer Drug Delivery

3. Polymeric theranostics: using polymer-based systems for simultaneous imaging and therapy

4. Fluorescent Nanoprobes Dedicated to in Vivo Imaging: From Preclinical Validations to Clinical Translation

5. Galactose Encapsulated Multifunctional Nanoparticle for HepG2 Cell Internalization

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanostructured Hybrid Polymer‐Lipid Drug Delivery Platforms for Rapamycin Repositioning in Anticancer Therapy;Advanced Therapeutics;2024-08-07

2. Lung Disease Management by Iloprost-Loaded Nanoparticles to Address Hyperinflammation Associated with Cystic Fibrosis;ACS Applied Nano Materials;2024-06-11

3. Sustained-Release Powders Based on Polymer Particles for Pulmonary Delivery of Beclomethasone Dipropionate in the Treatment of Lung Inflammation;Pharmaceutics;2023-04-14

4. Poly(lactic acid) and poly(lactic-co-glycolic acid)-based nanocarrier systems for theranostic applications;Polymeric Nanosystems;2023

5. Galactosylated Polymer/Gold Nanorods Nanocomposites for Sustained and Pulsed Chemo-Photothermal Treatments of Hepatocarcinoma;Pharmaceutics;2022-11-18